(NASDAQ: QTRX) Quanterix's forecast annual revenue growth rate of 0.65% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.92%.
Quanterix's revenue in 2025 is $137,421,000.On average, 2 Wall Street analysts forecast QTRX's revenue for 2025 to be $5,363,525,091, with the lowest QTRX revenue forecast at $5,185,930,058, and the highest QTRX revenue forecast at $5,541,120,123.
In 2026, QTRX is forecast to generate $6,326,532,216 in revenue, with the lowest revenue forecast at $6,072,741,935 and the highest revenue forecast at $6,580,322,498.